Gynecologic Oncology | Specialty

Risk Factors Identified for Detrimental Delays in Endometrial Cancer Surgery

September 2nd 2016

Emily M. Ko, MD, discusses the implications of two clinical trial findings for patients with endometrial cancer, and how several risk factors may lead to a surgical treatment delay.

Dr. Ko on Surgery as an Effective Option for Patients With Endometrial Cancer

August 23rd 2016

Emily Ko, MD, assistant professor of Obstetrics and Gynecology, University of Pennsylvania Health System, discusses why surgery is an effective option for patients with endometrial cancer.

Rio Grande Urology Expands With Gynecologic Oncology Collaboration

August 14th 2016

As a group, Rio Grande Urology shares a sense of obligation and culture. Its leaders have embraced an integrative model approach and sees the advantages of it.

FDA Approves First HPV Test for Use With SurePath Preservative Fluid

July 8th 2016

The FDA has approved the cobas HPV Test for use with SurePath Preservative Fluid for the detection of human papilloma virus (HPV) in cervical cells.

NCCN Introduces New Vulvar Cancer Guideline

April 4th 2016

A new NCCN guideline for the management of vulvar cancer outlines the use of resection, radiation therapy, and chemotherapy based on disease site and stage, recognizing that only 2 randomized treatment trials have been completed.

Trabectedin Significantly Slows Progression in Uterine Leiomyosarcoma

March 20th 2016

Treatment with trabectedin significantly improved progression-free survival compared with dacarbazine in women with advanced uterine leiomyosarcoma, according to a subgroup analysis of the phase III SAR-3007 trial.

Expert Sees Major Genomic Knowledge Gaps in Cervical Cancer

January 19th 2016

Today, in his laboratory at Columbia University, Murty Vundavalli, PhD continues working to understand the genetic and epigenetic aspects of cervical cancer in an attempt to elucidate prognostic markers of response to treatment.

Genome Sequencing Hints at New Targets for Cervical Cancer

January 14th 2016

With technological advancements in genome sequencing, researchers are now gaining a more detailed picture of the genetic drivers of cervical cancer and the important role that the human papillomavirus, responsible for the vast majority of cervical cancer cases, plays in molding the genetic profile of this disease.

BRCA+ Patients May Have Higher Risk of Serous Uterine Cancers After RRSO

October 15th 2015

Dr. Noah Kauff discusses how hysterectomy, in addition to standard risk-reducing salpingo-oophorectomy (RRSO) measures, should be considered in BRCA+women to reduce the risk of serous uterine cancers.

Fosaprepitant Improves Emesis Control in Women Receiving Chemoradiotherapy for Cervical Cancer

September 28th 2015

Adding fosaprepitant (Emend) to an antiemetic regimen significantly improved emesis control versus standard care in women receiving radiotherapy and cisplatin for cervical cancer.

Novel Immunotherapy Shows Promise in Metastatic Cervical Cancer

September 17th 2015

Tom Herzog, MD, discusses the vaccine ADXS11-001 (axalimogene filolisbac) in patients with persistent or recurrent metastatic cervical cancer.

Dr. Kauff on Challenges in Treating Uterine Cancer

August 19th 2015

Noah D. Kauff, MD, FACOG, gynecologist and geneticist, director, Ovarian Cancer Screening and Prevention, Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, discusses the main challenges in treating uterine cancer.

Palliative Care Issues in Gynecologic Cancer

August 17th 2015

Palliative care should address the unique symptom profile of gynecologic cancer and be tailored to individual socioeconomic environments.

Dr. Hashemi Sadraei Discusses Biomarkers in HPV-Induced Tumors

July 30th 2015

Nooshin Hashemi Sadraei, MD, assistant professor of medicine, Department of Internal Medicine, University of Cincinnati, discusses biomarkers in HPV-induced tumors, including cervical, anal, and oropharyngeal cancers.

Future of Ovarian and Cervical Cancers

July 2nd 2015

Treating Locally Advanced Cervical Cancer

July 2nd 2015

Prevention and Early Detection of Cervical Cancer

July 2nd 2015

Carboplatin Versus Cisplatin in Cervical Cancer

July 2nd 2015

Bevacizumab in Advanced Cervical Cancer

July 2nd 2015

Managing Platinum-Resistant Ovarian Cancer

July 2nd 2015